AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22284902
Drug: HM30181 360
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HM30181 360 mg single-dose
Trial: 22284902
Drug: HM30181 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HM30181 600 mg single-dose
Trial: 22284902
Drug: HM30181 900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HM30181 900 mg single-dose
Trial: 22284902
Drug: HM30181 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HM30181 60 mg multiple-dose
Trial: 22284902
Drug: HM30181 180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HM30181 180 mg multiple-dose
Trial: 22284902
Drug: HM30181 360
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HM30181 360 mg multiple-dose
Trial: 22284902
Drug: HM30181 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HM30181 (all doses)
Trial: 22284902
Drug: HM30181 (multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HM30181 (multiple doses)
Trial: 22284902
Drug: HM30181 (360
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HM30181 (360 mg repeated administration)
Trial: 15920044
Drug: C therapy
RxNorm normalized name: CARDIAC THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C therapy (combination therapy weight loss program for 2 years)
Trial: 15920044
Drug: S/C therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S/C therapy (standard therapy weight loss program for 1 year followed by combination therapy in the 2nd year)
Trial: 13679972
Drug: Immunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy with biologically standardized mushroom extract at a maintenance dosage of 0.1 mg/ml of Alt a I
Trial: 13679972
Drug: Immunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy with biologically standardized mushroom extract
Trial: 10479145
Drug: Nonavalent pneumococcal
RxNorm normalized name: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8
DrugBank: Streptococcus pneumoniae type 8 capsular polysaccharide antigen (DB10326)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonavalent pneumococcal conjugate vaccine
Trial: 29074892
Drug: No medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No medication for 14 days (Control)
Trial: 23949016
Drug: G-Bond (HEMA-free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-Bond (HEMA-free one-step adhesive)
Trial: 17662129
Drug: Pimecrolimus (Elidel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pimecrolimus (Elidel cream 1%)
Trial: 16098458
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg of imatinib daily
Trial: 16098458
Drug: Cross-over to
RxNorm normalized name: Red Cross Canker Sore
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cross-over to high-dose imatinib after progression on 400 mg
Trial: 16098458
Drug: Cross-over to
RxNorm normalized name: Red Cross Canker Sore
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cross-over to high-dose imatinib
Trial: 8583020
Drug: Modified Widman
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified Widman flap surgery and scaling and root planning with ibuprofen
Trial: 2407812
Drug: Adjuvant endocrine
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant endocrine therapy (tamoxifen 20 mg/d and low-dose prednisone 7.5 mg/d for one year)
Trial: 2407812
Drug: Observation (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Observation (no adjuvant therapy)
Trial: 7355185
Drug: 10 compound
RxNorm normalized name: Blackburn Compound
DrugBank: Drostanolone propionate (DB14655)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10 compound CS‐US trials
Trial: 7355185
Drug: 30 compound
RxNorm normalized name: Blackburn Compound
DrugBank: Drostanolone propionate (DB14655)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 30 compound CS‐US trials
Trial: 7355185
Drug: 30 compound
RxNorm normalized name: Blackburn Compound
DrugBank: Drostanolone propionate (DB14655)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 30 compound CS presentations and 30 shock stimuli (Control group)
Trial: 28982775
Drug: Virtual asthma
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Virtual asthma clinic (VAC) with 8-monthly outpatient visits and monthly web-based monitoring
Trial: 28982775
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care with 4-monthly outpatient visits
Trial: 19556410
Drug: 0.12% chlorhexidine
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 1.2 [iU] in 1 mL BUCCAL MOUTHWASH [0.12% Chlorhexidine Gluconate Oral Rinse]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.12% chlorhexidine digluconate oral care
Trial: 19556410
Drug: Oral care
RxNorm normalized name: Oral Care Q4 Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral care without antiseptic
Trial: 15081447
Drug: Caffeine (3.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (3.3 mg/kg, equivalent to 2 to 3 cups of brewed coffee)
Trial: 8288717
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg E3 suppository
Trial: 15840256
Drug: Fluvastatin 40
RxNorm normalized name: fluvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 40 mg once daily for 1 week
Trial: 15840256
Drug: Fluvastatin 80
RxNorm normalized name: fluvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 80 mg once daily for 1 week
Trial: 31894102
Drug: Deworming (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deworming (1 year after treatment)
Trial: 10924732
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid supplementation (1 g/day)
Trial: 9311486
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 150 mg.kg-1 in 250 mL of saline
Trial: 3724308
Drug: Flunitrazepam 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunitrazepam 1.0 mg
Trial: 24007748
Drug: Pomalidomide (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pomalidomide (4 mg/day on days 1-21) plus low-dose dexamethasone (40 mg/day on days 1, 8, 15, and 22)
Trial: 24007748
Drug: High-dose dexamethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose dexamethasone (40 mg/day on days 1-4, 9-12, and 17-20)
Trial: 27096106
Drug: Pomalidomide plus
RxNorm normalized name: Pomalidomide
DrugBank: Pomalidomide (DB08910)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Pomalidomide plus low-dose dexamethasone
Trial: 20215781
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (Vi-E) treatment on the blood-side layer of a synthetic polysulfone dialyzer
Trial: 20215781
Drug: Polysulfone (PS)
RxNorm normalized name: solasulfone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polysulfone (PS) dialyzer without Vi-E treatment
Trial: 16609356
Drug: [99mTc]pertechnetate salivary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: [99mTc]pertechnetate salivary gland scintigraphy (SGS) after intravenous injection of 370 MBq
Trial: 10720082
Drug: Ro 45-2081
RxNorm normalized name: RO-5045337
DrugBank: RO-5045337 (DB14793)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ro 45-2081 (50 mg, single intravenous injection)
Trial: 8874590
Drug: Intranasal desmopressin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal desmopressin (20 micrograms)
Trial: 24448692
Drug: Topiroxostat 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiroxostat 160 mg/day
Trial: 15821394
Drug: Atazanavir/ritonavir (ATV/RTV)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atazanavir/ritonavir (ATV/RTV) (300/100 mg) once daily
Trial: 15821394
Drug: Lopinavir/ritonavir (LPV/RTV)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lopinavir/ritonavir (LPV/RTV) (400/100 mg) twice daily
Trial: 15821394
Drug: Atazanavir/saquinavir (ATV/SQV)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atazanavir/saquinavir (ATV/SQV) (400/1200 mg) once daily
Trial: 10224988
Drug: Education through
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Education through monthly newsletters
Trial: 2069516
Drug: Surfactant inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surfactant inhalation (1 ml; 10 mg per milliliter)
Trial: 29579846
Drug: HTK +
RxNorm normalized name: Histidine-Tryptophan-Ketoglutarate Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HTK + UW solution
Trial: 26728882
Drug: Combination HIV-prevention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination HIV-prevention intervention
Trial: 18173139
Drug: Erzhi Tiangui
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erzhi Tiangui Granule (ETG) combined with Western medicine
Trial: 15309433
Drug: Extra virgin
RxNorm normalized name: Jarrow Formulas Extra Virgin Coconut Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extra virgin olive oil (EVOO) 40 mL/day
Trial: 15309433
Drug: Refined olive
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Refined olive oil (ROO) 40 mL/day
Trial: 12126548
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human growth hormone (rhGH), 4.5 U Bid for 5‐7 days
Trial: 7586252
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 15 g infused over 24 hours
Trial: 27695423
Drug: Resveratrol supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resveratrol supplementation (200 mg/day)
Trial: 25892271
Drug: Eptifibatide along
RxNorm normalized name: Eptifibatide
DrugBank: Eptifibatide (DB00063)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eptifibatide along with intensified antianginal therapy (group A)
Trial: 25892271
Drug: Intensified antianginal
RxNorm normalized name: ANTIANGINALS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensified antianginal therapy alone (group B)
Trial: 22867975
Drug: Etanercept (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept (12.5 mg) administered via intra-articular injections
Trial: 16034446
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 30 mg
Trial: 21193172
Drug: Atomoxetine (ATM)
DrugBank: Atomoxetine (DB00289)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atomoxetine (ATM) 60 mg
Trial: 21193172
Drug: Citalopram (CIT)
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Citalopram (CIT) 30 mg
Trial: 29762709
Drug: Relationship between
RxNorm normalized name: CYCLIZED P12 (PEPTIDE BOND BETWEEN THE CARBOXY AND AMINO-TERMINAL ENDS OF THE LINEAR PEPTIDE PSHISKYILRWRPK)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relationship between anti-KSHV antibodies and KSHV shedding
Trial: 29762709
Drug: Relationship between
RxNorm normalized name: CYCLIZED P12 (PEPTIDE BOND BETWEEN THE CARBOXY AND AMINO-TERMINAL ENDS OF THE LINEAR PEPTIDE PSHISKYILRWRPK)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relationship between antimalarial antibodies and KSHV shedding
Trial: 29328637
Drug: Cream containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream containing olive oil squalene
Trial: 29328637
Drug: Squalene-containing cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Squalene-containing cream
Trial: 31377226
Drug: AQP5 levels
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AQP5 levels in urine (measured in ng/mL)
Trial: 31377226
Drug: AQP5 levels
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AQP5 levels in the highest tertile (16.0 ng/mL)
Trial: 25077918
Drug: Acute administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acute administration of 8 mg salbutamol
Trial: 25077918
Drug: Two-week administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-week administration of 8 mg salbutamol
Trial: 22906006
Drug: VXM01 (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VXM01 (oral DNA vaccine)
Trial: 17606778
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C 200 mg daily for fifty days
Trial: 17606778
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C 500 mg daily for fifty days
Trial: 17606778
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C 1500 mg daily for fifty days
Trial: 10341162
Drug: D-tagatose (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-tagatose (75 g daily for 8 weeks)
Trial: 10341162
Drug: D-tagatose (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-tagatose (75 g single dose)
Trial: 10341162
Drug: Sucrose (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucrose (25 g with each meal for 8 weeks)
Trial: 10341162
Drug: No sugar
RxNorm normalized name: polyamino sugar condensate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No sugar supplements (for Type 2 diabetics for 8 weeks)
Trial: 2022861
Drug: Polyantibiotic cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyantibiotic cream applied three times daily from the first day of catheterization until bacteriuria was found.
Trial: 2022861
Drug: Routine meatal
RxNorm normalized name: URETHRAL MEATAL DILATOR ADULT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine meatal care with cleansing of the meatal surface during daily bathing (Control).
Trial: 7078021
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg of norethindrone acetate and 50 microgram ethinyl estradiol daily for 21 days with 7 days of placebo treatment in each cycle
Trial: 7078021
Drug: One fifth
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One fifth of the hormone dose in form of a continuous daily medication
Trial: 7078021
Drug: Previous use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Previous use of oral contraceptives
Trial: 18422480
Drug: Prescription omega-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescription omega-3 fatty acid concentrates (P-OM3)
Trial: 16638830
Drug: Daily gauze
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily gauze dressing
Trial: 10975022
Drug: Lidamidine HCL
RxNorm normalized name: lidamidine HCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidamidine HCL (4 mg) taken orally t.i.d. with food
Trial: 8973430
Drug: Separate injections
RxNorm normalized name: Atractylis separate root
DrugBank: Atractylodes lancea root (DB14693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate injections of DTP-a, Hib conjugate, and i.p.v.
Trial: 6146112
Drug: Camazepam (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Camazepam (30 mg)
Trial: 29572795
Drug: Paclitaxel and
RxNorm normalized name: paclitaxel and encequidar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel and carboplatinum (first-line therapy)
Trial: 29572795
Drug: Cisplatinum-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatinum-based therapy (including doxorubicin and cyclophosphamide)
Trial: 24519843
Drug: Impact of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Impact of dialysis on daily life
Trial: 20814785
Drug: Propofol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (200 mcg/kg/min)
Trial: 20814785
Drug: Propofol (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (120 mcg/kg/min) plus remifentanil (0.3 mcg/kg/min)
Trial: 24092691
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate (0.3 g/kg)
Trial: 16247118
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of both (brace and physical therapy)
Trial: 12073163
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg L-5-hydroxytryptophan
Trial: 7749496
Drug: CV 205‐502
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CV 205‐502 (0.15 mg)
Trial: 7749496
Drug: Octreotide (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide (0.1 mg)
Trial: 7749496
Drug: CV 205‐502
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CV 205‐502 (0.3 mg/day) - chronic test
Trial: 7749496
Drug: CV 205‐502
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CV 205‐502 (0.6 mg/day) and octreotide (0.6 mg/day) - combined therapy for 3 months
Trial: 1483496
Drug: Intravenous famotidine
RxNorm normalized name: Famotidine
DrugBank: Famotidine (DB00927)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous famotidine (20 mg)
Trial: 3791364
Drug: placebo solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo solution
Trial: 31168645
Drug: Caudal epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal epidural steroid injections (ESIs)
Trial: 29190751
Drug: Beetroot-based gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beetroot-based gel (BG) 100 g containing 12 mmol nitrate
Trial: 29190751
Drug: Nitrate-depleted gel
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate-depleted gel (PLA) 100 g
Trial: 16717300
Drug: N-acetylcysteine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (150 mg/kg mixed in 250 mL of 5% dextrose infused in 20 min, followed by an infusion of 150 mg/kg in 250 mL of 5% dextrose over 24 h)
Trial: 29966458
Drug: DNR 36
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DNR 36 mg/m2
Trial: 29966458
Drug: DOX 30
RxNorm normalized name: BenzoDox 30 Kit
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DOX 30 mg/m2
Trial: 24410834
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy with pitavastatin
Trial: 24410834
Drug: Intensive lipid-lowering
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive lipid-lowering therapy with pitavastatin
Trial: 19414572
Drug: 0.8 mg
RxNorm normalized name: biotin 0.8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 mg iclaprim/kg
Trial: 19414572
Drug: 1.6 mg
RxNorm normalized name: menthol 1.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.6 mg iclaprim/kg
Trial: 19414572
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g vancomycin
Trial: 17456225
Drug: Grass allergen
RxNorm normalized name: orchardgrass allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grass allergen tablet (GRAZAX)
Trial: 17456225
Drug: Symptomatic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptomatic treatment (antihistamines and topical steroids)
Trial: 15006124
Drug: Prescription by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescription by general practitioners for brisk exercise (30 minutes per day, 5 days per week)
Trial: 15006124
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of prescription and counselling
Trial: 11605558
Drug: Semantically similar
RxNorm normalized name: Antigonadotropins and similar agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semantically similar encoding pairs (e.g., alluring-PRETTY)
Trial: 11605558
Drug: Semantically contrasting
RxNorm normalized name: CONTRAST MEDIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semantically contrasting encoding pairs (e.g., drab-PRETTY)
Trial: 11605558
Drug: Semantically unrelated
RxNorm normalized name: Latanoprost related compound e
DrugBank: Latanoprost acid (DB19360)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semantically unrelated encoding pairs (e.g., sore-PRETTY)
Trial: 11605558
Drug: Semantically similar
RxNorm normalized name: Antigonadotropins and similar agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semantically similar generation pairs (e.g., beautiful-PRETTY)
Trial: 11605558
Drug: Semantically contrasting
RxNorm normalized name: CONTRAST MEDIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semantically contrasting generation pairs (e.g., ugly-PRETTY)
Trial: 9520826
Drug: Demeclocycline (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Demeclocycline (1200 mg daily, starting 5 days preoperatively to postoperative day 2)
Trial: 8084686
Drug: Training in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Training in sports (field hockey and athletics) for 10 weeks, 45 minutes daily
Trial: 28688677
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) applied with an InGaAlP diode (660nm‐100mW‐1J‐4J/cm2)
Trial: 9429740
Drug: Direct administration
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct administration into the duodenum (40 mg)
Trial: 9429740
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration (40 mg)